Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 15:6:47.
doi: 10.1186/s13756-017-0208-x. eCollection 2017.

The threat of antimicrobial resistance in developing countries: causes and control strategies

Affiliations
Review

The threat of antimicrobial resistance in developing countries: causes and control strategies

James A Ayukekbong et al. Antimicrob Resist Infect Control. .

Abstract

The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients' behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring.

Keywords: Antimicrobial therapy; Developing countries; Microorganisms; Resistance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105–110. doi: 10.1016/j.ijantimicag.2004.02.015. - DOI - PubMed
    1. Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–1098. doi: 10.1016/S1473-3099(13)70318-9. - DOI - PubMed
    1. Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect. Dis. 2005;5:568–580. - PubMed
    1. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect. Dis. 2005;5:481–493. - PubMed
    1. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317:647–650. doi: 10.1136/bmj.317.7159.647. - DOI - PMC - PubMed

LinkOut - more resources